Holen Sie sich die Stockscreener-App
1.81
8.12%
-0.16
Handel nachbörslich:
1.84
0.03
+1.66%
Schlusskurs vom Vortag:
$1.97
Offen:
$1.93
24-Stunden-Volumen:
178.82K
Relative Volume:
0.15
Marktkapitalisierung:
$73.01M
Einnahmen:
$13.42M
Nettoeinkommen (Verlust:
$-73.35M
KGV:
-0.9427
EPS:
-1.92
Netto-Cashflow:
$-56.34M
1W Leistung:
+77.45%
1M Leistung:
+115.19%
6M Leistung:
+72.38%
1J Leistung:
+25.26%
1-Tages-Spanne:
$1.76
$1.95
1-Wochen-Bereich:
$1.00
$2.92
52-Wochen-Spanne:
$0.64
$2.92
Barinthus Biotherapeutics Plc Adr Stock (BRNS) Company Profile
Firmenname
Barinthus Biotherapeutics Plc Adr
Sektor
Branche
Telefon
44 (0) 1865 818808
Adresse
UNIT 6-10, ZEUS BUILDING, DIDCOT
Vergleichen Sie BRNS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BRNS
Barinthus Biotherapeutics Plc Adr
|
1.81 | 41.15M | 13.42M | -73.35M | -56.34M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Barinthus Biotherapeutics Plc Adr Stock (BRNS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-25 | Eingeleitet | Jefferies | Buy |
| 2021-05-25 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-05-25 | Eingeleitet | William Blair | Outperform |
| 2021-05-24 | Eingeleitet | H.C. Wainwright | Buy |
Barinthus Biotherapeutics Plc Adr Aktie (BRNS) Neueste Nachrichten
BRNS’s Market Whiplash: 50.99% YTD Rise, 152.41% Rise in 30 Days - investchronicle.com
BRNS stock touches 52-week low at $0.8 amid market volatility - Investing.com UK
Dollar General Corp (DG) Shares Up Despite Recent Market Volatility - The News Heater
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Strong Buy: Here's Why - MSN
Exclusive-Mexico's Pemex, billionaire Slim renegotiate deepwater gas project - Yahoo Finance
RBC raises Reckitt Benckiser stock target to £57.00, keeps outperform - MSN
Stocks Generating Improved Relative Strength: Revolution Medicines - MSN
Barinthus Bio shifts focus, cuts workforce to extend cash runway - Investing.com
The big rebrand: Why these 4 biopharmas changed their name this year - PharmaVoice
Barinthus Bio intiates Phase 1 clinical trial of VTP-1000 for treatment of coeliac disease - European Pharmaceutical Manufacturer
Mexico Shingles Vaccine Market Size & Outlook, 2023-2030 - Grand View Research
Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time - MarketBeat
Finanzdaten der Barinthus Biotherapeutics Plc Adr-Aktie (BRNS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):